Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey R Fineman

Showing results (1-10 of 181) with videos related to

Pageof 19
Sort By:
American Journal of Respiratory and Critical Care Medicine|April 10, 2020
Equipoise and Acumen in Pediatric Acute Respiratory Distress Syndrome ResearchPeter Oishi, Jeffrey R Fineman
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|January 8, 2004
Pharmacologic therapy for persistent pulmonary hypertension of the newborn: as "poly" as the disease itselfPeter Oishi, Jeffrey R Fineman
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|August 5, 2016
Pulmonary HypertensionPeter Oishi, Jeffrey R Fineman
Pulmonary Circulation|January 8, 2025
New Insights Into Pediatric Pulmonary Hypertension From Bogota: Is Younger Always Better?Michael A Smith, Jeffrey R Fineman
American Journal of Respiratory and Critical Care Medicine|November 16, 2016
The Prescient Prognosticator? Hepatoma-derived Growth Factor in Pulmonary HypertensionRebecca Johnson Kameny, Jeffrey R Fineman
Vascular Pharmacology|October 20, 2006
Oxidative and nitrosative stress in pediatric pulmonary hypertension: roles of endothelin-1 and nitric oxideStephen M Black, Jeffrey R Fineman
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|July 11, 2006
BNP for pediatrics--not quite ready for primetimePeter E Oishi, Jeffrey R Fineman
JACC. Basic to Translational Science|March 29, 2021
Pulmonary Arteriovenous Malformations and the Hepatic "Black Box": Are We Emerging From the Darkness?Satish K Rajagopal, Jeffrey R Fineman
Children (Basel, Switzerland)|June 24, 2022
Progress in Pulmonary Vein Stenosis: Lessons from Success in Treating Pulmonary Arterial HypertensionKathy J Jenkins, Jeffrey R Fineman
American Journal of Physiology. Heart and Circulatory Physiology|April 18, 2006
Sp3 inhibits Sp1-mediated activation of the cardiac troponin T promoter and is downregulated during pathological cardiac hypertrophy in vivoAnthony Azakie, Jeffrey R Fineman, Youping He
Pageof 19

Showing results (1-10 of 181) with videos related to

Sort By:
Pageof 19
American Journal of Respiratory and Critical Care Medicine|April 10, 2020
Equipoise and Acumen in Pediatric Acute Respiratory Distress Syndrome ResearchPeter Oishi, Jeffrey R Fineman
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|January 8, 2004
Pharmacologic therapy for persistent pulmonary hypertension of the newborn: as "poly" as the disease itselfPeter Oishi, Jeffrey R Fineman
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|August 5, 2016
Pulmonary HypertensionPeter Oishi, Jeffrey R Fineman
Pulmonary Circulation|January 8, 2025
New Insights Into Pediatric Pulmonary Hypertension From Bogota: Is Younger Always Better?Michael A Smith, Jeffrey R Fineman
American Journal of Respiratory and Critical Care Medicine|November 16, 2016
The Prescient Prognosticator? Hepatoma-derived Growth Factor in Pulmonary HypertensionRebecca Johnson Kameny, Jeffrey R Fineman
Vascular Pharmacology|October 20, 2006
Oxidative and nitrosative stress in pediatric pulmonary hypertension: roles of endothelin-1 and nitric oxideStephen M Black, Jeffrey R Fineman
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|July 11, 2006
BNP for pediatrics--not quite ready for primetimePeter E Oishi, Jeffrey R Fineman
JACC. Basic to Translational Science|March 29, 2021
Pulmonary Arteriovenous Malformations and the Hepatic "Black Box": Are We Emerging From the Darkness?Satish K Rajagopal, Jeffrey R Fineman
Children (Basel, Switzerland)|June 24, 2022
Progress in Pulmonary Vein Stenosis: Lessons from Success in Treating Pulmonary Arterial HypertensionKathy J Jenkins, Jeffrey R Fineman
American Journal of Physiology. Heart and Circulatory Physiology|April 18, 2006
Sp3 inhibits Sp1-mediated activation of the cardiac troponin T promoter and is downregulated during pathological cardiac hypertrophy in vivoAnthony Azakie, Jeffrey R Fineman, Youping He
Pageof 19